GlassScriptPhysician profile
Maria M Chaudhry
NPI 1184935298
$14,708.66
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
See the full distribution for Hematology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,971 · 2020: $2,600 · 2021: $1,965 · 2022: $6,173.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $9,876.36 | 2019-2022 | |
| Glaxosmithkline, LLC. | $4,619.59 | 2019-2021 | |
| Celgene Corporation | $115.85 | 2019 | |
| Janssen Biotech, INC. | $82.11 | 2019 | |
| Incyte Corporation | $14.75 | 2021 |
3 companies reported research payments only; those appear in the research section below.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maria Chaudhry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.